Collective Intelligence

The first interactive platform that brings together innovation players around common interest.

Success story – NVision raised $52.2M for MRI Hyperpolarization Tech for cancer diagnosis

Detected in 2020 by Blumorpho, NVision Imaging was selected by the Editorial Committee of INPHO to join the 7th edition of this exclusive investor gathering and raised a substantial amount in 2023.

Our comment :

NVision Imaging, a Germany-based developer of MRI polarizers and hyperpolarized imaging agents, raised $52.2M in Series A funding, including $19.5M from the German Government, and won the INPHO Award 2020, operated by Blumorpho.
Joana Foglia, Investors relation

Success story – NVision raised $52.2M for MRI Hyperpolarization Tech for cancer diagnosis

Detected in 2020 by Blumorpho, NVision Imaging was selected by the Editorial Committee of INPHO to join the 7th edition of this exclusive investor gathering and raised a substantial amount in 2023.

BLUMORPHO comment :

NVision Imaging, a Germany-based developer of MRI polarizers and hyperpolarized imaging agents, raised $52.2M in Series A funding, including $19.5M from the German Government, and won the INPHO Award 2020, operated by Blumorpho.
Joana Foglia, Investors relation

Success story – NVision raised $52.2M for MRI Hyperpolarization Tech for cancer diagnosis

Detected in 2020 by Blumorpho, NVision Imaging was selected by the Editorial Committee of INPHO to join the 7th edition of this exclusive investor gathering and raised a substantial amount in 2023.

BLUMORPHO comment :

NVision Imaging, a Germany-based developer of MRI polarizers and hyperpolarized imaging agents, raised $52.2M in Series A funding, including $19.5M from the German Government, and won the INPHO Award 2020, operated by Blumorpho.
Joana Foglia, Investors relation

Our previous articles